Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9P5D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $42,217
Award facts
- Contract value 100% obligated
- $42,216.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $42,216.66 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens (2 mL units) on December 2, 2025, with an ultimate completion date of December 3, 2025. This non-set-aside contract is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999 and extends through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated significant capacity to fulfill federal medical procurement requirements through multiple competitive awards with the Defense Logistics Agency. The Dupixent delivery supports the federal military and veteran healthcare systems' pharmaceutical needs, adding to the contractor's extensive portfolio of medical product deliveries including brand-name medications, generics, vaccines, and specialized medical supplies across multiple therapeutic domains. As a child contract under the larger SPE2DX IDC vehicle, this award exemplifies the company's role as a critical vendor within DLA's Medical Supply Chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26F9P5D?
SPE2DR26F9P5D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 2, 2025.
How much is contract SPE2DR26F9P5D worth?
The government has obligated $42,217 on SPE2DR26F9P5D.
Is contract SPE2DR26F9P5D an order under another contract?
Yes. SPE2DR26F9P5D is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9P5D competed?
The extent of competition for SPE2DR26F9P5D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award